COVID-19 Project Team: Difference between revisions

Revision as of 21:16, 12 August 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

'COVID-19 constant Update" Aisha Adigun, M.D Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Gastrointestinal disorders and COVID-19

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members

Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members

Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members

Endocrinology and COVID-19

Infectious diseases and COVID-19

@@ Line 8: / Line 8: @@
 === {{AE}} ===
+{{Multicol}}
-;
 * The name of the leaders are written in '''bold''':
+'''COVID-19 constant Update''"
+[[User:Aisha Adigun|Aisha Adigun, M.D]]
 '''Cardiovascular Disorders of COVID-19 Team Members'''
 *[[User:Behjat|Alieh Bahjat, M.D.]]
 *'''[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]'''
@@ Line 61: / Line 61: @@
 *[[User:NNikravangolsefid|Nasrin Nikravangolsefid, M.D, MPH]]
 *[[User:MydahSajid|Mydah Sajid, M.D.]]
+{{ColBreak}}
 '''Neurologic Disorders and COVID-19 Team Members'''
 *'''[[User:Fahimeh Shojaei |Fahimeh Alsadat Shojaei, M.D.]]'''
@@ Line 81: / Line 81: @@
 *[[User:Rija Gul|Rija Gul, M.B.B.S]]
 *Rana Aljebzi (not trained yet)
 '''Endocrinology and COVID-19'''
 *'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]'''
 '''Infectious diseases and COVID-19'''
 *Harmeet, MD
 *Zaida, MD
+{{ColBreak}}